There is no Morningtar’s Analysis data available.
Protalex Inc is a United States-based clinical stage company. It is primarily focused on the development of biopharmaceutical drugs for treating autoimmune and inflammatory diseases including rheumatoid arthritis and immune thrombocytopenia. The key product candidate of the group is PRTX-100, an immunomodulatory therapy, which is a bacterial protein known to modify aspects of the human immune system. PRTX-100 is effective in animal models of autoimmune diseases and has demonstrated activity on cultured human immune cells at very low concentrations.
Florham Park, NJ, 07932